| Rumsey Oates, | |
|
2501 Jackson Ave, Point Pleasant, WV 25550-2035 | |
| (304) 675-2303 | |
| (304) 675-7762 |
| Full Name | Rumsey Oates |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2501 Jackson Ave, Point Pleasant, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376814855 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP0003287 (West Virginia) | Primary |
| 183500000X | Pharmacist | 03212867 (Ohio) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Rumsey Oates, 2501 Jackson Ave, Point Pleasant, WV 25550-2035 Ph: (304) 675-2303 | Rumsey Oates, 2501 Jackson Ave, Point Pleasant, WV 25550-2035 Ph: (304) 675-2303 |
News Archive
Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.
When girls with symptoms of autism or ADHD seek professional medical help, their problems are often played down or misinterpreted, and there is a real risk that they will not get the help or support they need. As such, more training is needed in this area, particularly in the public sector, reveals a thesis from the University of Gothenburg.
Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata's lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.
New Hampshire Public Radio: A bill in the state legislature would create an annual public report that details the causes of rising health spending by analyzing now-private information that doctors, hospitals and other health organizations would have to provide to the state's Department of Insurance. The move is partly in response to conflicting narratives: The state's health spending continues to rise, yet hospitals and doctors say they are struggling (Grant, 2/17).
In a new study published in Science Signaling, Cleveland Clinic researchers have identified a novel target for new therapies that may help to treat or prevent a host of fibrotic conditions, which contribute to nearly half of overall mortality in the United States.
› Verified 3 days ago
John Michael Beaver Ii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2520 Valley Dr, Point Pleasant, WV 25550 Phone: 304-674-2412 Fax: 304-675-7150 | |
Dr. Dakota Toth, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Jackson Ave, Point Pleasant, WV 25550 Phone: 304-675-2303 | |
Jamie Bennett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Jackson Ave, Point Pleasant, WV 25550 Phone: 304-675-2303 | |
Dr. Michael Durst, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 Ohio River Rd, Point Pleasant, WV 25550 Phone: 304-675-1612 | |
Dr. Christopher Childress, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2501 Jackson Ave, Point Pleasant, WV 25550 Phone: 304-675-2303 | |
Gary Hatfield Ii, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 Ohio River Rd, Point Pleasant, WV 25550 Phone: 304-675-1612 |